Ledger.Open graph →
SEC Form D · filed October 18, 2023

i2O Therapeutics, Inc

Offering
$4.0M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Christopher Gagliardi · Cambridge, MADirectorKurt Graves · Saratoga, CAExec · DirectorAnthony Aiudi · Cambridge, MADirectorChristopher Gagliardi · Cambridge, MADirectorKurt Graves · Saratoga, CAExec · DirectorAnthony Aiudi · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗